TotalMarketCap

Sol-Gel Technologies

SLGLNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$206.295 M

$63.01 -4.53%

Close of 6 Nov 2026

As of 6 Nov 2026, Sol-Gel Technologies (SLGL) has a market capitalization of $206.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$19.4M

#2976 by revenue

Earnings

-$6.13M

Loss-making

Shares outstanding

2,786,158

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #243AC ImmuneACIU$212.7M
  2. #244ADC TherapeuticsADCT$207.5M
  3. #245Sol-Gel TechnologiesSLGL$206.3M
  4. #246Cartesian TherapeuticsRNAC$205.2M
  5. #247Bright Minds BiosciencesDRUG$201.3M

What if Sol-Gel Technologies were worth as much as…

Open the what-if tool →

Gold $28.2T

$8,624,582

Per share 136,876× higher

Bitcoin $1.53T

$466,661.13

Per share 7,406× higher

Apple $5.02T

$1,532,005

Per share 24,314× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Sol-Gel Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.